Hartford Funds Management Co LLC Has $2.45 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Hartford Funds Management Co LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 23.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,645 shares of the healthcare conglomerate’s stock after purchasing an additional 896 shares during the period. UnitedHealth Group makes up 0.2% of Hartford Funds Management Co LLC’s holdings, making the stock its 9th biggest holding. Hartford Funds Management Co LLC’s holdings in UnitedHealth Group were worth $2,446,000 as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of the business. Robbins Farley bought a new stake in shares of UnitedHealth Group during the third quarter worth about $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. CGC Financial Services LLC grew its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA raised its stake in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $5.33 during midday trading on Tuesday, reaching $483.70. 3,366,904 shares of the stock were exchanged, compared to its average volume of 4,466,545. The firm has a market cap of $445.04 billion, a PE ratio of 29.57, a PEG ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company’s fifty day moving average is $484.44 and its 200-day moving average is $513.42. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the business posted $6.26 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Royal Bank of Canada lowered their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Truist Financial reaffirmed a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Bank of America restated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.